drugset / Trial / NCT00384410

Use of the Cannabinoid Nabilone for the Promotion of Sleep in Chronic, Non-Malignant Pain Patients

NCT00384410

RandomizedCrossoverDouble-blindTreatment

Summary

Sleep disturbance is perhaps one of the most prevalent complaints of patients with long-standing painful conditions. Nabilone is a medication that is approved by Health Canada as an anti-emetic (prevent vomiting) for patients undergoing chemotherapy. Nabilone, due to its sleep promoting properties, is sometimes prescribed by physicians to pain patients to help improve their sleep. However, there is no direct research evidence to either support or refute this practice. This study will investigate if nabilone is effective in improving sleep in insomnia and pain patients.

Timeline

Start
2005-12
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Nabilone Other / unclassified

Indications